Following intranasal administration, however, the mean bioavailability of dihydroergotamine mesylate is 32% relative to the injectable administration
Inflammation of blood vessels (vasculitis) can cause fragile vessels and skin changes, leading to bruising or purpura
Designing therapies that modulate these interactions requires not only precision but also an appreciation of the balance between protective and harmful outcomes
The SURMOUNT-4 trial assessed the weight maintenance with tirzepatide and had also two periods: a 36-week open-label lead-in period during which all participants took tirzepatide, followed by a 52-week double-blind treatment period during which participants were randomised to either continue on tirzepatide or switch to placebo
Many individuals under conventional treatment become further dysfunctional from the over-load of medications used for treating the complaints and not the root cause
When its levels increase, it means the liver is damaged or not functioning properly
